Cargando…

Acquired von Willebrand Disease Secondary to Clear Cell Renal Cell Carcinoma

Background: Acquired von Willebrand disease (AvWD) is a rare and often underdiagnosed disease that typically is associated with lymphoproliferative, cardiovascular disease, and myeloproliferative disease. It is challenging to diagnose as it requires a hemostatic challenge to present itself. Case Pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Odom, Brian, Khourdaji, Iyad, Golas, Victoria, Zekman, Richard, Rosenberg, Bradley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056257/
https://www.ncbi.nlm.nih.gov/pubmed/30065959
http://dx.doi.org/10.1089/cren.2018.0032
_version_ 1783341314432040960
author Odom, Brian
Khourdaji, Iyad
Golas, Victoria
Zekman, Richard
Rosenberg, Bradley
author_facet Odom, Brian
Khourdaji, Iyad
Golas, Victoria
Zekman, Richard
Rosenberg, Bradley
author_sort Odom, Brian
collection PubMed
description Background: Acquired von Willebrand disease (AvWD) is a rare and often underdiagnosed disease that typically is associated with lymphoproliferative, cardiovascular disease, and myeloproliferative disease. It is challenging to diagnose as it requires a hemostatic challenge to present itself. Case Presentation: This is a 46-year-old male with a history of multiple sclerosis complicated by neurogenic bladder who presented with intermittent gross painless hematuria. He underwent a gross hematuria workup. Cystoscopy demonstrated active bleeding from the right ureteral orifice. CT Urogram showed a filling defect in the right renal pelvis and endophytic 3 cm solid, enhancing left kidney mass. The patient underwent diagnostic cystourethroscopy, bilateral retrograde pyelogram demonstrating no filling defects bilaterally. Right ureteropyeloscopy demonstrated diffuse patchy erythema of the infrarenal collecting system with biopsies obtained. His postoperative course was complicated by gross hematuria requiring cystoscopy which demonstrated no upper tract bleeding and small pulsatile bleeding vessel in the bladder requiring cauterization. Hematology was consulted to rule out bleeding diathesis with workup demonstrating a von Willebrand deficiency (vWD). He had no family history of vWD and an AvWD was suspected. Hematologic workup was consistent with AvWD, type 2B vWD also known as a platelet-type von Willebrand disease. Renal pelvis biopsies were negative for pathology. Further investigation of the left renal mass confirmed a biopsy-proven clear cell renal cell carcinoma (ccRCC). He underwent a laparoscopic left radical nephrectomy with final pathology demonstrating pT1 ccRCC with negative margins. Postoperatively his repeat laboratories demonstrated normal factor VIII activity, ristocetin cofactor, and vWF antigen with normalized activated partial thromboplastin time. Follow-up imaging demonstrated no further evidence of disease supporting the hypothesis of a paraneoplastic syndrome from his ccRCC that caused an AvWD. Conclusion: This is the first case report to our knowledge of a paraneoplastic AvWD secondary to ccRCC. This should be on your differential when there is abnormal bleeding in the setting of renal masses.
format Online
Article
Text
id pubmed-6056257
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Mary Ann Liebert, Inc.
record_format MEDLINE/PubMed
spelling pubmed-60562572018-07-31 Acquired von Willebrand Disease Secondary to Clear Cell Renal Cell Carcinoma Odom, Brian Khourdaji, Iyad Golas, Victoria Zekman, Richard Rosenberg, Bradley J Endourol Case Rep Article Background: Acquired von Willebrand disease (AvWD) is a rare and often underdiagnosed disease that typically is associated with lymphoproliferative, cardiovascular disease, and myeloproliferative disease. It is challenging to diagnose as it requires a hemostatic challenge to present itself. Case Presentation: This is a 46-year-old male with a history of multiple sclerosis complicated by neurogenic bladder who presented with intermittent gross painless hematuria. He underwent a gross hematuria workup. Cystoscopy demonstrated active bleeding from the right ureteral orifice. CT Urogram showed a filling defect in the right renal pelvis and endophytic 3 cm solid, enhancing left kidney mass. The patient underwent diagnostic cystourethroscopy, bilateral retrograde pyelogram demonstrating no filling defects bilaterally. Right ureteropyeloscopy demonstrated diffuse patchy erythema of the infrarenal collecting system with biopsies obtained. His postoperative course was complicated by gross hematuria requiring cystoscopy which demonstrated no upper tract bleeding and small pulsatile bleeding vessel in the bladder requiring cauterization. Hematology was consulted to rule out bleeding diathesis with workup demonstrating a von Willebrand deficiency (vWD). He had no family history of vWD and an AvWD was suspected. Hematologic workup was consistent with AvWD, type 2B vWD also known as a platelet-type von Willebrand disease. Renal pelvis biopsies were negative for pathology. Further investigation of the left renal mass confirmed a biopsy-proven clear cell renal cell carcinoma (ccRCC). He underwent a laparoscopic left radical nephrectomy with final pathology demonstrating pT1 ccRCC with negative margins. Postoperatively his repeat laboratories demonstrated normal factor VIII activity, ristocetin cofactor, and vWF antigen with normalized activated partial thromboplastin time. Follow-up imaging demonstrated no further evidence of disease supporting the hypothesis of a paraneoplastic syndrome from his ccRCC that caused an AvWD. Conclusion: This is the first case report to our knowledge of a paraneoplastic AvWD secondary to ccRCC. This should be on your differential when there is abnormal bleeding in the setting of renal masses. Mary Ann Liebert, Inc. 2018-07-01 /pmc/articles/PMC6056257/ /pubmed/30065959 http://dx.doi.org/10.1089/cren.2018.0032 Text en © Brian Odom et al. 2018; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Odom, Brian
Khourdaji, Iyad
Golas, Victoria
Zekman, Richard
Rosenberg, Bradley
Acquired von Willebrand Disease Secondary to Clear Cell Renal Cell Carcinoma
title Acquired von Willebrand Disease Secondary to Clear Cell Renal Cell Carcinoma
title_full Acquired von Willebrand Disease Secondary to Clear Cell Renal Cell Carcinoma
title_fullStr Acquired von Willebrand Disease Secondary to Clear Cell Renal Cell Carcinoma
title_full_unstemmed Acquired von Willebrand Disease Secondary to Clear Cell Renal Cell Carcinoma
title_short Acquired von Willebrand Disease Secondary to Clear Cell Renal Cell Carcinoma
title_sort acquired von willebrand disease secondary to clear cell renal cell carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056257/
https://www.ncbi.nlm.nih.gov/pubmed/30065959
http://dx.doi.org/10.1089/cren.2018.0032
work_keys_str_mv AT odombrian acquiredvonwillebranddiseasesecondarytoclearcellrenalcellcarcinoma
AT khourdajiiyad acquiredvonwillebranddiseasesecondarytoclearcellrenalcellcarcinoma
AT golasvictoria acquiredvonwillebranddiseasesecondarytoclearcellrenalcellcarcinoma
AT zekmanrichard acquiredvonwillebranddiseasesecondarytoclearcellrenalcellcarcinoma
AT rosenbergbradley acquiredvonwillebranddiseasesecondarytoclearcellrenalcellcarcinoma